Accelerating Medicines Partnership launches data knowledge portal for Parkinson’s disease

The Accelerating Medicines Partnership (AMP) program for Parkinson’s disease (PD) has launched a data portal to provide de-identified information collected from 4,298 PD patients and healthy controls to researchers working to develop effective therapies for the disease.
Avatar
Aiden Stastny